Citichem India Reports FY26 Audited Financials

Citichem India's Revenue from operations at ₹9.48 crore in FY26, down 49.3% from ₹18.70 crore in FY25. Profit after tax at ₹1.00 crore in FY26, down 18.7% from ₹1.23 crore in FY25.

Reader Takeaway: Top-line contraction explained by one-off income; contingent liabilities pose a risk.

What just happened

Citichem India Limited announced its audited financial results for the fiscal year ending March 31, 2026. Key highlights include a significant 49.3% year-on-year decrease in revenue from operations, which stood at ₹9.48 crore. Total revenue also saw a substantial drop of 71.7% to ₹15.48 crore. Consequently, profit after tax (PAT) declined by 18.7% to ₹1.00 crore.

The company reported an unmodified audit opinion and confirmed that all its IPO proceeds have been fully utilized as per the prospectus. A notable financial achievement is the complete repayment of its long-term debt, bringing it down to nil as of March 31, 2026.

Why this matters

For investors, the sharp decline in revenue requires understanding the underlying causes. While the company attributes the drop in total revenue largely to a one-time accounting write-back of sundry creditors in the previous year (FY25), the contraction in core operational revenue is a critical factor. The moderate decline in PAT despite the revenue fall suggests cost management or operational efficiencies.

The full utilization of IPO proceeds indicates adherence to strategic plans. The elimination of long-term debt improves the company's balance sheet strength, reducing financial risk. However, significant contingent liabilities related to Income Tax demands remain a key concern.

The backstory

In FY25, Citichem India's total revenue was inflated by a substantial one-time accounting write-back of sundry creditors, amounting to ₹35.68 crore. This non-recurring income significantly boosted the previous year's financials. The current FY26 results reflect a normalization after this one-off event. The company had also reported long-term borrowings of ₹0.62 crore in the prior year.

What changes now

With IPO proceeds fully deployed and long-term debt cleared, the company's financial structure is leaner. Investors will now focus on the core business operations to drive future revenue and profitability. The company must manage its operational performance and address the pending tax-related contingent liabilities.

Risks to watch

The primary risk is the significant contingent liabilities of ₹21.44 crore related to Income Tax demands. Unfavorable outcomes in these legal matters could materially impact the company's financial health. Additionally, the substantial drop in revenue requires careful monitoring to ensure the core business can achieve growth without relying on one-time accounting adjustments.

Peer comparison

Information on specific chemical sector peers' recent performance is not provided in the filing. Investors may wish to compare Citichem India's revenue growth and profitability metrics against other small-cap chemical manufacturers operating in similar segments.

Context metrics (time-bound)

• Revenue from operations: FY26: ₹9.48 Cr | FY25: ₹18.70 Cr | Change: (49.3%)
• Total Revenue: FY26: ₹15.48 Cr | FY25: ₹54.73 Cr | Change: (71.7%)
• Profit after tax: FY26: ₹1.00 Cr | FY25: ₹1.23 Cr | Change: (18.7%)
• Long-term Debt: FY26: ₹0 Cr | FY25: ₹0.62 Cr | Change: (100%)
• Short-term Borrowings: FY26: ₹7.72 Cr | FY25: ₹4.77 Cr
• Cash and cash equivalents: FY26: ₹0.66 Cr | FY25: ₹4.46 Cr

What to track next

Investors should closely monitor the company's quarterly results to assess the trajectory of its core operational revenue. Keeping abreast of any developments regarding the Income Tax demands and contingent liabilities will be crucial for risk assessment.